2-(4-bromo-2-fluorophenyl)ethanamine

4-Bromo-2-fluorobenzeneethanamine is a competitive prostate-specific membrane antigen binding agent for reduction of non-target organ uptake of radiolabeled PSMA inhibitors for PSMA positive tumor imaging and radiopharmaceutical therapy.